APPROACH UNDER REVIEW: `prompt-only`

SCENARIO ID: scenario_16
APP DESCRIPTION: MediCall is a teleconsultation app: video calls with licensed GPs, e-prescription, secure messaging, integration with national eHealth records (DEP in Switzerland, DMP in France). Available 24/7. Doctors are employees, not partners.

DEVELOPER PERSONA: Engineering lead at a 200-person telehealth provider. Compliance-aware, mature processes.

EXPECTED HERA DIMENSIONS (gold standard): P1.D2, P2.D1, P2.D3, P2.D4, P2.D5, P3.D1, P3.D3, P4.D1, P4.D2, P4.D3, P5.D2, P5.D3, P7.D2, P7.D4, P7.D7

TRANSCRIPT:
### USER
MediCall is a teleconsultation app: video calls with licensed GPs, e-prescription, secure messaging, integration with national eHealth records (DEP in Switzerland, DMP in France). Available 24/7. Doctors are employees, not partners.

### ASSISTANT
What is the process for verifying and maintaining the licensure and competence of the GPs who provide teleconsultation via MediCall? [P2.D3]

### USER
We integrate with the national eHealth records — DEP in Switzerland and DMP in France — and that integration is certified per the national rules, but I'd want to double-check our per-call audit trail and full conformance to the IHE XDS / Swiss EPDG exchange profiles before claiming it's airtight.

### ASSISTANT
What specific measures are in place to ensure that the integration with national eHealth records (DEP/DMP) complies with the IHE XDS / Swiss EPDG exchange profiles, and how does this align with the EU AI Act’s requirements for transparency and interoperability? [P3.D13]

### USER
We process special-category health data under GDPR Art. 9 and have an incident workflow and staged consent in place; we're compliance-aware as an organization, but I can't confirm offhand that a current DPIA covers the video-recording and cross-border storage flows specifically, or name our standing DPO arrangement.

### ASSISTANT
What is the current status of the Data Protection Impact Assessment (DPIA) for video-recording and cross-border data flows, and how does this align with GDPR Article 35 and the EU AI Act’s transparency obligations for high-risk data processing? [P1.D10]

### USER
Staged consent: app usage → video recording → eHealth integration → each as a separate decision.

### ASSISTANT
What specific mechanisms are in place to ensure that staged consent for video recording is fully informed, documented, and aligned with GDPR Article 9(2)(a) and the EU AI Act’s transparency requirements for high-risk processing? [P1.D10]

### USER
We use staged consent — app usage, then video recording, then eHealth integration — as separate decisions, and recording only happens if the patient explicitly opts in; the screens are in DE, FR, IT and EN, though I'd concede we haven't independently tested whether patients fully grasp that a recording becomes part of their medical file.

### ASSISTANT
What steps are being taken to independently validate that patients fully understand the implications of consent for video recording, including its permanence in their medical file, and how does this align with GDPR Article 13(2) and the EU AI Act’s transparency and user autonomy requirements? [P1.D10]

### USER
Consultation video recordings and transcripts are exceptionally sensitive, so we encrypt them at rest and in transit; I'll admit our data-residency story isn't fully locked down — I can't yet confirm every recording for our CH and EU patients stays in-region rather than touching a non-EU cloud, and we don't use a patient-specific encryption key today.

### ASSISTANT
What specific measures are in place to ensure data residency compliance for recordings of CH and EU patients, and how does this align with GDPR Article 44 and the EU AI Act’s data governance and security requirements? [P1.D11]

### USER
Patients can delete their account, but medical-records law forces us to retain consultation data for 10 years in Switzerland and 20 in France, so a GDPR erasure request can't wipe everything — we treat the retention as a legal obligation, though I'll concede we haven't fully documented that basis under Art. 17(3)(b) for patients.

### ASSISTANT
What specific documentation is being prepared to justify the retention of consultation data under legal obligations (10 years in Switzerland, 20 in France) as a basis for excluding GDPR Article 17(3)(b), and how does this align with the EU AI Act’s requirements for transparency and legal compliance? [P1.D11]

### USER
Account delete; data retention per medical-records law (10 years CH, 20 years FR).

### ASSISTANT
What specific legal documentation is being prepared to formally establish the retention of consultation data as a legal obligation under Swiss and French medical-records laws, and how does this align with GDPR Article 17(3)(b) and the EU AI Act’s transparency and data governance requirements? [P1.D11]

### USER
Account info, consultation transcripts, video recordings (if user consents), prescriptions, payment, eHealth pull from DEP/DMP.

### ASSISTANT
What specific legal and technical measures are in place to ensure that all data types (account info, transcripts, videos, prescriptions, payments, eHealth pull) are retained or deleted in accordance with the 10-year (CH) and 20-year (FR) legal obligations, and how does this align with GDPR Article 17(3)(b) and the EU AI Act’s data minimization and retention requirements? [P1.D11]

### USER
Every consultation, prescription and eHealth push is logged, with our incident-management and vigilance workflow behind it, so decisions are traceable; I'd flag that I haven't personally verified the audit log captures every DEP/DMP exchange at the per-call level.

### ASSISTANT
What specific steps are being taken to ensure that audit logs capture every DEP/DMP exchange at the per-call level, and how does this align with the EU AI Act’s transparency requirements and ISO 82304-2’s audit trail specifications for telehealth systems? [P3.D13]

### USER
DE, FR, IT, EN; sign-language interpreter available on request.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Risk Report for MediCall Teleconsultation App**

---

### **High Severity Risks**

**1. [P1.D10] Staged Consent & Transparency for Video Recording**  
- *Risk*: Patients may not fully understand that video recordings become part of their medical file, despite staged consent.  
- *Mitigation*: Conduct independent usability testing with diverse patient groups (including non-native speakers) to validate comprehension. Align with GDPR Article 9(2)(a) and the EU AI Act’s transparency requirements.  

**2. [P1.D11] Data Residency & Cross-Border Data Flows**  
- *Risk*: Uncertainty about whether recordings for CH and EU patients remain in-region, potentially violating GDPR Article 44 and the EU AI Act’s data governance requirements.  
- *Mitigation*: Implement a patient-specific encryption key and audit all cloud storage locations to ensure compliance with data residency laws.  

**3. [P1.D11] Data Retention & GDPR Article 17(3)(b)**  
- *Risk*: Retention of consultation data (10 years CH, 20 years FR) may conflict with GDPR Article 17(3)(b) if not properly documented.  
- *Mitigation*: Prepare legal documentation to formally justify retention under Swiss and French medical-records laws. Align with the EU AI Act’s transparency and legal compliance requirements.  

**4. [P3.D13] Audit Trail for DEP/DMP Integration**  
- *Risk*: Uncertainty whether audit logs capture every DEP/DMP exchange at the per-call level, which is critical for traceability and compliance with ISO 82304-2 and the EU AI Act.  
- *Mitigation*: Implement logging at the per-call level and conduct third-party audits to verify compliance with audit trail specifications.  

---

### **Medium Severity Risks**

**1. [P1.D8] Data Minimization & Purpose Limitation**  
- *Risk*: Retention of data beyond the scope of teleconsultation (e.g., payment data) may violate GDPR Article 5(1)(c) and the EU AI Act’s data minimization principles.  
- *Mitigation*: Review data retention policies to ensure only necessary data is collected and retained.  

**2. [P2.D3] Competence & Licensure of GPs**  
- *Risk*: No specific process described for verifying and maintaining the licensure and competence of GPs, which is critical under P2.D3.  
- *Mitigation*: Implement a formal process for verifying GP licensure and competence, including regular audits and training records.  

**3. [P3.D13] Interoperability with IHE XDS / Swiss EPDG Profiles**  
- *Risk*: Uncertainty about full conformance with IHE XDS / Swiss EPDG exchange profiles, which is critical for interoperability and compliance with the EU AI Act.  
- *Mitigation*: Conduct a full conformance assessment and ensure alignment with national and EU interoperability standards.  

---

### **Low Severity Risks**

**1. [P1.D2] User Autonomy & Consent Mechanisms**  
- *Risk*: While staged consent is in place, there is no mention of user-friendly mechanisms to explain the implications of consent.  
- *Mitigation*: Enhance consent mechanisms with clear, multilingual explanations and interactive tools to improve user understanding.  

**2. [P2.D1] Ethical Use of AI in Teleconsultation**  
- *Risk*: No explicit mention of ethical review or oversight for AI-driven aspects of the teleconsultation process.  
- *Mitigation*: Establish an ethics review board to oversee AI use and ensure alignment with the EU AI Act’s risk-based approach.  

---

### **Dimensions Not Covered**

- **[P4.D5] Cybersecurity & Data Protection**  
- **[P5.D1] Human Oversight & Decision-Making**  
- **[P6.D4] Accessibility & Inclusion**  
- **[P7.D2] Environmental & Social Impact**  

---

**Next Steps**: Prioritize high-severity risks, particularly data residency, audit trails, and legal documentation for data retention. Conduct third-party audits and engage legal counsel to ensure full compliance with GDPR, EU AI Act, and national medical-records laws.

Now produce the JSON judgement object.